Cargando…
Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 varia...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770918/ https://www.ncbi.nlm.nih.gov/pubmed/29282274 http://dx.doi.org/10.1136/bmjopen-2017-019503 |
_version_ | 1783293161582362624 |
---|---|
author | Corrao, Giovanni Rea, Federico Di Martino, Mirko De Palma, Rossana Scondotto, Salvatore Fusco, Danilo Lallo, Adele Belotti, Laura Maria Beatrice Ferrante, Mauro Pollina Addario, Sebastiano Merlino, Luca Mancia, Giuseppe Carle, Flavia |
author_facet | Corrao, Giovanni Rea, Federico Di Martino, Mirko De Palma, Rossana Scondotto, Salvatore Fusco, Danilo Lallo, Adele Belotti, Laura Maria Beatrice Ferrante, Mauro Pollina Addario, Sebastiano Merlino, Luca Mancia, Giuseppe Carle, Flavia |
author_sort | Corrao, Giovanni |
collection | PubMed |
description | OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 variables (measured from inpatient diagnoses and outpatient drug prescriptions within 2 years before baseline) independently predicting 1-year mortality in a sample of 500 000 individuals aged 50 years or older randomly selected from the NHS beneficiaries of the Italian region of Lombardy (training set) was developed. The corresponding weights were assigned from the regression coefficients of a Weibull survival model. MCS performance was evaluated by using an internal (ie, another sample of 500 000 NHS beneficiaries from Lombardy) and three external (each consisting of 500 000 NHS beneficiaries from Emilia-Romagna, Lazio and Sicily) validation sets. Discriminant power and net reclassification improvement were used to compare MCS performance with that of other comorbidity scores. MCS ability to predict secondary health outcomes (ie, hospital admissions and costs) was also investigated. RESULTS: Primary and secondary outcomes progressively increased with increasing MCS value. MCS improved the net 1-year mortality reclassification from 27% (with respect to the Chronic Disease Score) to 69% (with respect to the Elixhauser Index). MCS discrimination performance was similar in the four regions of Italy we tested, the area under the receiver operating characteristic curves (95% CI) being 0.78 (0.77 to 0.79) in Lombardy, 0.78 (0.77 to 0.79) in Emilia-Romagna, 0.77 (0.76 to 0.78) in Lazio and 0.78 (0.77 to 0.79) in Sicily. CONCLUSION: MCS seems better than conventional scores for predicting health outcomes, at least in the general population from Italy. This may offer an improved tool for risk adjustment, policy planning and identifying patients in need of a focused treatment approach in the everyday medical practice. |
format | Online Article Text |
id | pubmed-5770918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57709182018-01-19 Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy Corrao, Giovanni Rea, Federico Di Martino, Mirko De Palma, Rossana Scondotto, Salvatore Fusco, Danilo Lallo, Adele Belotti, Laura Maria Beatrice Ferrante, Mauro Pollina Addario, Sebastiano Merlino, Luca Mancia, Giuseppe Carle, Flavia BMJ Open Public Health OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 variables (measured from inpatient diagnoses and outpatient drug prescriptions within 2 years before baseline) independently predicting 1-year mortality in a sample of 500 000 individuals aged 50 years or older randomly selected from the NHS beneficiaries of the Italian region of Lombardy (training set) was developed. The corresponding weights were assigned from the regression coefficients of a Weibull survival model. MCS performance was evaluated by using an internal (ie, another sample of 500 000 NHS beneficiaries from Lombardy) and three external (each consisting of 500 000 NHS beneficiaries from Emilia-Romagna, Lazio and Sicily) validation sets. Discriminant power and net reclassification improvement were used to compare MCS performance with that of other comorbidity scores. MCS ability to predict secondary health outcomes (ie, hospital admissions and costs) was also investigated. RESULTS: Primary and secondary outcomes progressively increased with increasing MCS value. MCS improved the net 1-year mortality reclassification from 27% (with respect to the Chronic Disease Score) to 69% (with respect to the Elixhauser Index). MCS discrimination performance was similar in the four regions of Italy we tested, the area under the receiver operating characteristic curves (95% CI) being 0.78 (0.77 to 0.79) in Lombardy, 0.78 (0.77 to 0.79) in Emilia-Romagna, 0.77 (0.76 to 0.78) in Lazio and 0.78 (0.77 to 0.79) in Sicily. CONCLUSION: MCS seems better than conventional scores for predicting health outcomes, at least in the general population from Italy. This may offer an improved tool for risk adjustment, policy planning and identifying patients in need of a focused treatment approach in the everyday medical practice. BMJ Publishing Group 2017-12-26 /pmc/articles/PMC5770918/ /pubmed/29282274 http://dx.doi.org/10.1136/bmjopen-2017-019503 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Public Health Corrao, Giovanni Rea, Federico Di Martino, Mirko De Palma, Rossana Scondotto, Salvatore Fusco, Danilo Lallo, Adele Belotti, Laura Maria Beatrice Ferrante, Mauro Pollina Addario, Sebastiano Merlino, Luca Mancia, Giuseppe Carle, Flavia Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title | Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title_full | Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title_fullStr | Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title_full_unstemmed | Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title_short | Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy |
title_sort | developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from italy |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770918/ https://www.ncbi.nlm.nih.gov/pubmed/29282274 http://dx.doi.org/10.1136/bmjopen-2017-019503 |
work_keys_str_mv | AT corraogiovanni developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT reafederico developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT dimartinomirko developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT depalmarossana developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT scondottosalvatore developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT fuscodanilo developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT lalloadele developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT belottilauramariabeatrice developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT ferrantemauro developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT pollinaaddariosebastiano developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT merlinoluca developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT manciagiuseppe developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly AT carleflavia developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly |